Ayuko Hoshino

Title: Ayuko Hoshino: Innovator in Cancer Treatment

Introduction

Ayuko Hoshino is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. Her work focuses on the determination and treatment of organotropic metastasis, which is crucial for improving cancer prognosis and management.

Latest Patents

Ayuko Hoshino holds a patent for "Methods and reagents for determination and treatment of organotropic metastasis." This invention relates to methods and kits for prognosing, treating, and managing cancer in a subject. The methods involve selecting a subject with cancer and obtaining a sample containing exosomes or an S100 molecule. The samples are then analyzed using reagents to detect the presence or absence of specific integrins or S100 molecules. This innovative approach allows for better prognosis and management of cancer treatment.

Career Highlights

Ayuko Hoshino is affiliated with Cornell University, where she continues her research and development in cancer treatment. Her work has garnered attention for its potential to improve patient outcomes and provide more effective treatment options.

Collaborations

Some of her notable coworkers include Bruno Da Silva and David C. Lyden. Their collaborative efforts contribute to advancing research in cancer treatment and enhancing the understanding of metastasis.

Conclusion

Ayuko Hoshino is a trailblazer in the field of cancer research, with her innovative patent paving the way for improved treatment methodologies. Her contributions are vital for the ongoing fight against cancer, and her work continues to inspire future innovations in the medical field.